160 related articles for article (PubMed ID: 31326612)
1. Low-Dose Cotrimoxazole Administered in Hematopoietic Stem Cell Transplant Recipients as Prophylaxis for Pneumocystis jirovecii Pneumonia Is Effective in Prevention of Infection due to Nocardia.
Gkirkas K; Stamouli M; Thomopoulos T; Kontos F; Kavatha D; Siafakas N; Karagiannidou A; Pournaras S; Antoniadou A; Tsirigotis P
Biol Blood Marrow Transplant; 2019 Sep; 25(9):e298-e299. PubMed ID: 31326612
[No Abstract] [Full Text] [Related]
2. Pneumocystis jirovecii pneumonia is rare in renal transplant recipients receiving only one month of prophylaxis.
Anand S; Samaniego M; Kaul DR
Transpl Infect Dis; 2011 Dec; 13(6):570-4. PubMed ID: 22093215
[TBL] [Abstract][Full Text] [Related]
3. Failures of once-a-week trimethoprim-sulfamethoxazole prophylaxis in children undergoing allogeneic hematopoietic stem cell transplant.
Castagnola E; Mesini A; Saffioti C; Moscatelli A; Pierri F; Giardino S; Faraci M
Transpl Infect Dis; 2020 Feb; 22(1):e13231. PubMed ID: 31846143
[TBL] [Abstract][Full Text] [Related]
4. Pentamidine for Prophylaxis against Pneumocystis jirovecii Pneumonia in Pediatric Oncology Patients Receiving Immunosuppressive Chemotherapy.
Quinn M; Fannin JT; Sciasci J; Bragg A; Campbell PK; Carias D; Crews KR; Gregornik D; Jeha S; Maron G; Pauley JL; Swanson HD; Wolf J; Greene W
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866879
[No Abstract] [Full Text] [Related]
5. Pneumocystis jirovecii Pneumonia Prophylaxis with Intravenous Pentamidine in Adult Allogeneic Hematopoietic Stem Cell Transplant Patients.
McCollam S; Lewis JS; Bubalo J; Diaz A
Antimicrob Agents Chemother; 2022 Nov; 66(11):e0083322. PubMed ID: 36214573
[TBL] [Abstract][Full Text] [Related]
6. Nocardia infection in lung transplant recipients.
Husain S; McCurry K; Dauber J; Singh N; Kusne S
J Heart Lung Transplant; 2002 Mar; 21(3):354-9. PubMed ID: 11897524
[TBL] [Abstract][Full Text] [Related]
7. Nocardiosis in Immunocompromised Patients on Alternative Pneumocystis Prophylaxis.
Puing AG; Epstein DJ; Banaei N; Subramanian AK; Liu AY
Emerg Infect Dis; 2021 Oct; 27(10):2734-2736. PubMed ID: 34545802
[TBL] [Abstract][Full Text] [Related]
8. High incidence of Pneumocystis jirovecii pneumonia in allogeneic hematopoietic cell transplant recipients in the modern era.
Evernden C; Dowhan M; Dabas R; Chaudhry A; Kalra A; Dharmani-Khan P; Gregson D; Johnson A; Jupp J; Jimenez-Zepeda V; Jamani K; Duggan P; Tay J; Khan F; Daly A; Storek J
Cytotherapy; 2020 Jan; 22(1):27-34. PubMed ID: 31889628
[TBL] [Abstract][Full Text] [Related]
9. Increased Incidence of Nocardial Infections in an Era of Atovaquone Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant Recipients.
Molina A; Winston DJ; Pan D; Schiller GJ
Biol Blood Marrow Transplant; 2018 Aug; 24(8):1715-1720. PubMed ID: 29555315
[TBL] [Abstract][Full Text] [Related]
10. Retrospective review of intravenous pentamidine for Pneumocystis pneumonia prophylaxis in allogeneic hematopoietic stem cell transplantation.
Diri R; Anwer F; Yeager A; Krishnadasan R; McBride A
Transpl Infect Dis; 2016 Feb; 18(1):63-9. PubMed ID: 26606757
[TBL] [Abstract][Full Text] [Related]
11. Tolerability of low-dose sulfamethoxazole/trimethoprim for Pneumocystis jirovecii pneumonia prophylaxis in kidney transplant recipients.
Zmarlicka M; Martin ST; Cardwell SM; Nailor MD
Prog Transplant; 2015 Sep; 25(3):210-6. PubMed ID: 26308779
[TBL] [Abstract][Full Text] [Related]
12. Dapsone safety in hematology patients: Pathways to optimizing Pneumocystis jirovecii pneumonia prophylaxis in hematology malignancy and transplant recipients.
Urbancic KF; Pisasale D; Wight J; Trubiano JA
Transpl Infect Dis; 2018 Dec; 20(6):e12968. PubMed ID: 30030892
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of low-dose cotrimoxazole prophylaxis against Pneumocystis carinii pneumonia after renal and/or pancreas transplantation.
Elinder CG; Andersson J; Bolinder G; Tydén G
Transpl Int; 1992 May; 5(2):81-4. PubMed ID: 1627244
[TBL] [Abstract][Full Text] [Related]
14. Combination of caspofungin and low-dose trimethoprim/sulfamethoxazole for the treatment of severe Pneumocystis jirovecii pneumonia in renal transplant recipients.
Tu GW; Ju MJ; Xu M; Rong RM; He YZ; Xue ZG; Zhu TY; Luo Z
Nephrology (Carlton); 2013 Nov; 18(11):736-42. PubMed ID: 24571744
[TBL] [Abstract][Full Text] [Related]
15. Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies, 2014.
Cooley L; Dendle C; Wolf J; Teh BW; Chen SC; Boutlis C; Thursky KA
Intern Med J; 2014 Dec; 44(12b):1350-63. PubMed ID: 25482745
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation.
Prasad GVR; Beckley J; Mathur M; Gunasekaran M; Nash MM; Rapi L; Huang M; Zaltzman JS
BMC Infect Dis; 2019 Apr; 19(1):311. PubMed ID: 30953458
[TBL] [Abstract][Full Text] [Related]
17. Is cotrimoxazole prophylaxis against Pneumocystis jirovecii pneumonia needed in patients with systemic autoimmune rheumatic diseases requiring immunosuppressive therapies?
Pereda CA; Nishishinya-Aquino MB; Brito-García N; Díaz Del Campo Fontecha P; Rua-Figueroa I
Rheumatol Int; 2021 Aug; 41(8):1419-1427. PubMed ID: 33656582
[TBL] [Abstract][Full Text] [Related]
18. Effective Pneumocystis jiroveci pneumonia prophylaxis with trimethoprim-sulfamethoxazole once a day twice a week.
Bostrom BC
Pediatr Blood Cancer; 2009 Aug; 53(2):239. PubMed ID: 19422030
[No Abstract] [Full Text] [Related]
19. Effectiveness and tolerability of intravenous pentamidine for Pneumocystis carinii pneumonia prophylaxis in adult hematopoietic stem cell transplant patients: a retrospective study.
Awad WB; Asaad A; Al-Yasein N; Najjar R
BMC Infect Dis; 2020 Jun; 20(1):400. PubMed ID: 32503449
[TBL] [Abstract][Full Text] [Related]
20. Should patients with malignancy receive chemoprophylaxis against Pneumocystis jirovecii pneumonia?
Barbounis V
Nat Clin Pract Oncol; 2005 Oct; 2(10):490-1. PubMed ID: 16205763
[No Abstract] [Full Text] [Related]
[Next] [New Search]